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ABSTRACT
 
—Transforming growth factor-
 
α
 
 (TGF-
 
α
 
), a member of the epidermal growth factor (EGF) fam-
ily, is produced within the mouse anterior pituitaries. However, the cell types of TGF-
 
α
 
-expressing cells and
the physiological roles of TGF-
 
α
 
 within mouse pituitary glands remain unclear. The aim of the present study
was to localize TGF-
 
α
 
 mRNA-expressing cells, and to clarify the involvement of TGF-
 
α
 
 in estrogen-induced
DNA replication in mouse anterior pituitary cells. Northern blot analysis demonstrated TGF-
 
α
 
 mRNA
expression in adult male and female mouse anterior pituitaries. 
 
In situ
 
 hybridization analysis of the pitu-
itaries in these mice showed that TGF-
 
α
 
 mRNA-expressing cells in the anterior pituitary are round, oval,
and medium-sized. TGF-
 
α
 
 mRNA was colocalized in most of the growth hormone (GH) mRNA-expressing
cells, while only some of the prolactin (PRL) mRNA-expressing cells. DNA replication in the anterior pitu-
itary cells was detected by monitoring the cellular uptake of a thymidine analogue, bromodeoxyuridine
(BrdU) in a primary serum-free culture system. Estradiol-17
 
β
 
 (E2) and TGF-
 
α
 
 treatment increased the
number of BrdU-labelled mammotrophs, indicating that E2 and TGF-
 
α
 
 treatment stimulates the DNA rep-
lication in mammotrophs. Immunoneutralization of TGF-
 
α
 
 with anti-TGF-
 
α
 
-antibodies nullified the E2-
induced increase in DNA replication. RT-PCR analysis of TGF-
 
α
 
 mRNA expression in ovariectomized
female mice revealed that E2 increases TGF-
 
α
 
 mRNA levels. These results indicate that the TGF-
 
α
 
 pro-
duced primarily in the somatotrophs mediates the stimulatory effects of estrogen on the DNA replication
of pituitary cells in a paracrine or autocrine manner.
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INTRODUCTION
 
Many lines of evidence have shown that the develop-
ment and function of pituitary cells are regulated by a para-
crine or autocrine control with hormones, growth factors,
and cytokines produced from the pituitary cells (Schwartz
and Cherny, 1992; Denef, 1994; Takahashi, 1995; Renner
 
et al.,
 
 1996; Ray and Melmed, 1997; Schwartz, 2000).
Among the various growth factors synthesized in the ante-
rior pituitary glands, members of the epidermal growth factor
(EGF) family appear to be involved in the regulation of cor-
ticotrophs and mammotrophs (Childs
 
 et al.,
 
 1995; Fan and
Childs, 1995; Oomizu
 
 et al.,
 
 2000). Transforming growth fac-
tor-
 
α
 
 (TGF-
 
α
 
) belongs to the epidermal growth factor (EGF)
family and shares the EGF-receptor (EGF-R) with EGF
(Marquardt
 
 et al.,
 
 1983; Massague, 1990). TGF-
 
α
 
 is pro-
duced in the pituitary glands of several species (Kudlow and
Kobrin, 1984; Kobrin
 
 et al.,
 
 1987; Lazar and Blum, 1992).
TGF-
 
α
 
 in the pituitary gland has been localized to certain
cell types, most notably mammotrophs and somatotrophs
(Kobrin
 
 et al.
 
, 1987). In rat pituitary cells, TGF-
 
α
 
 mRNA is
expressed in somatotrophs, gonadotrophs, and mammotro-
phs (Fan and Childs, 1995). Immunoreactive EGF-Rs have
been observed in subsets of all cell types of rat pituitary
secretory cells, but only in some pituitary cells (Fan and
Childs, 1995; Armstrong and Childs, 1997). Borgundvaag 
 
et
al
 
. (1992) have reported that chronic estrogen treatment
induces a concurrent increase in the pituitary weight and
TGF-
 
α
 
 production, concluding that TGF-
 
α
 
 is involved in
estrogen-induced pituitary growth. We have directly demon-
strated that TGF-
 
α
 
 treatment stimulates DNA replication in
mammotrophs and corticotrophs 
 
in vitro
 
 (Oomizu
 
 et al.
 
,
2000). However, in mouse pituitaries, the cell types of TGF-
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α
 
 expressing cells are unknown, and the relationship
between estrogen-induced DNA replication and TGF-
 
α
 
-
induced replication is unclear. The aim of the present study
was to identify the type of cells that express TGF-
 
α
 
 mRNA
and to clarify the mechanism of estrogen-induced DNA rep-
lication in the mouse pituitary. Expression of TGF-
 
α
 
 mRNA
was studied by Northern blot analysis. The types of cells
expressing TGF-
 
α
 
 mRNA were studied by 
 
in situ
 
 hybridiza-
tion, and the effects of E2 on TGF-
 
α
 
 synthesis were studied
by reverse transcription-polymerase chain reaction (RT-
PCR).
 
MATERIALS AND METHODS
 
Animals
 
Adult male and female mice of the ICR strain (CLEA Japan
Inc., Osaka, Japan) were housed in a temperature-controlled room
with free access to the CE-7 commercial diet (CLEA Japan Inc.)
and water. All animal care and experiments were carried out
according to the Guidelines of Animal Experimentation, Faculty of
Science, Okayama University, Japan.
 
Northern blot analysis
 
Total RNA from the anterior pituitaries of ovariectomized
female mice was extracted using the method of Chomczynski and
Sacchi (1987). Total cellular RNA was denatured by incubation at
65
 
°
 
C for 15 min with 1
 
×
 
MOPS, (0.02 M MOPS, 8 mM sodium ace-
tate, 1 mM EDTA), 2.2 M formaldehyde and 50% (w/v) formamide.
Total RNA (10 
 
µ
 
g) was electrophoresed on a 1% agarose gel. The
RNA was transferred to a nylon membrane (hybond-N+ Amersham,
Arlington Hights, IL) by electroblotting (30 V, 16 hr). The transferred
RNA was fixed with an UV lamp for 5 min. The membrane was pre-
hybridized in 5
 
×
 
SSPE, 50% formamide, 5
 
×
 
Denhardt’s solution, 10%
dextran sulfate, and 1 mg/ml herring sperm DNA at 42
 
°
 
C for 2 hr.
Hybridization was carried out at 42
 
°
 
C for 16 hr in hybridization
buffer containing 50 ng [
 
α
 
-
 
32
 
P]dCTP-labelled probe. After the
hybridization, the membrane was washed with 1
 
×
 
SSC and 0.1%
SDS at 42
 
°
 
C for 20 min and 0.5
 
×
 
SSC and 0.1% SDS at 42
 
°
 
C for
20 min. Hybridized signals were detected by autoradiography.
 
In situ
 
 hybridization analysis of TGF-α
 
 mRNA-expressing cells
 
Pituitaries were quickly fixed overnight in 4% paraformalde-
hyde in 0.01 M phosphate-buffered saline (PBS, pH 7.6) at 4
 
°
 
C.
They were then embedded in paraffin and sectioned at a thickness
of 5 
 
µ
 
m thick. The sections were digested with 10 mg/ml proteinase
K (Merck, Darmstad, Germany) at 37
 
°
 
C for 30 min. The reaction of
proteinase K was blocked by 0.2% (w/v) glycine in 0.01 M PBS. The
sections were fixed with 4% paraformaldehyde in 0.01 M PBS and
were incubated in 0.25% acetic anhydride in 0.1M triethanolamine
for 10 min at room temperature. The mouse TGF-
 
α
 
 cDNA probe
(pcrmTGF
 
α
 
-ST1), rat GH cDNA probe, and rat PRL cDNA probe
were labelled with digoxigenin (DIG)-11-UTP at 37
 
°
 
C overnight (20
hr) by random primer using the DIG DNA labeling and detection kit
(Boehringer Mannheim, Germany). pBR328 plasmids were labelled
and used as a negative control for 
 
in situ
 
 hybridization.
The sections were hybridized at 42
 
°
 
C overnight in a solution of
5
 
×
 
SSPE, 1
 
×
 
Denhardt’s solution, 10% (w/v) sodium dextran sulfate,
50% (v/v) deionized formamide, 120 
 
µ
 
g/ml denatured herring sperm
DNA, and 0.3 ng/
 
µ
 
l DIG-labelled probe. The slides were washed in
1
 
×
 
SSC at room temperature for 10 min followed by 1
 
×
 
SSC and
0.5
 
×
 
SSC at 45
 
°
 
C for 15 min each. The final wash was carried out
in 0.2 
 
×
 
 SSC at room temperature for 1 min. Nonspecific binding
was blocked by 0.5% (w/v) BSA in TN buffer (0.1 M Tris-HCl, 0.3
M NaCl, pH 7.5) for 30 min. Anti-DIG-alkaline phosphatase conju-
gate (1:1000) was applied to the slides and kept at room tempera-
ture for 1 hr. The slides were washed twice in 0.2% (v/v) Tween 20
TN buffer for 10 min. Nitro blue tetrazolium (NBT) and 5-bromo-4-
chloro-3-indolyl phosphate (BCIP) were used as chromogens for
hybridization detection. Color development was carried out for 20 hr
at room temperature.
 
Preparation of cDNA Probes
 
A 502-bp mouse TGF-
 
α
 
 cDNA clone (pcrmTGF
 
α
 
-ST1) was
generated as follows. DNA fragments encoding a portion of mouse
TGF-
 
α
 
 was obtained from total RNA from ICR mice by RT-PCR.
Oligonucleotide primers for TGF-
 
α
 
 were designed based upon the
mouse sequence and were synthesized by the Gibco BRL Custom
Primers, Life Technologies Asia Pacific (Yokohama, Japan). The
primer sequences and the location on the nucleotide sequences
were as follows: TGF-
 
α
 
 5' (AGCCAGAAGAAGCAAGCCATCACT,
367–390), TGF-
 
α
 
 3' (CTCATTCTCGGTGTGGGTTAGCAA, 845–
868). The cDNA fragments were subcloned into pGEM3zf(+).
Clones were sequenced using fluorescent primers and an auto-
mated DNA sequencer, and were confirmed to be cDNAs encoding
a portion of the mouse TGF-
 
α
 
.
The rat GH cDNA (790 bp) cloned to the 
 
Hind
 
 III site of the
plasmid pBR322, and rat PRL cDNA (823 bp) cloned to the 
 
Pst
 
 1
site of the plasmid pBR322 were kindly provided by Dr. J.A. Martial
(University of Liege, Belgium).
 
Isolation of pituitary cells
 
Anterior pituitaries obtained from 2-month-old male mice were
dissociated with 0.5% trypsin (0.5% w/v; DIFCO, Detroit, MI) as pre-
viously described (Oomizu
 
 et al.,
 
 1998). Cell viability was checked
using the trypan blue exclusion test and was usually found to be
more than 95%. The isolated pituitary cells were suspended in a 1:1
mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12
medium without phenol red (DMEM/F12 medium, Sigma Chemical
Co., St. Louis, MO) containing fetal calf serum (FCS, 10%, v/v;
Gibco BRL, Life Technologies, Inc., Rockville, MD). The cells were
seeded on poly-L-lysine-(Sigma Chemical Co.) coated plastic cov-
erslips (diameter 13 mm; Sumitomo, Tokyo, Japan) in 24-well tis-
sue-culture plates (Becton Dickinson, Lincoln Park, NJ) at a cell
density of 5 
 
×
 
 10
 
5
 
 cells/ml per well. The culture was allowed to pro-
ceed in a humidified atmosphere of 5% CO
 
2
 
 and 95% air at 37
 
°
 
C.
 
Exposure to a TGF-α
 
-specific antibody
 
After a 3-day culture in DMEM/F12 medium containing 10%
FCS, the pituitary cells were cultured in serum-free DMEM/F12
medium supplemented with hydrocortisone (100 
 
µ
 
g/l), triiodothyro-
nine (400 ng/l), transferrin (10 mg/l), bovine glucagon (10 ng/ml),
parathyroid hormone (200 ng/l), insulin (1 
 
µ
 
g/l), and sodium selenite
(5 
 
µ
 
g/l) for another 3 days. Each treatment was performed on three
plastic coverslips. An antibody specific for human TGF-
 
α
 
 (1 
 
µ
 
g IgG,
Ab-3, Oncogene Science, Uniondale, NY) was added to the
medium (500 
 
µ
 
l) for 5 days with estradiol-17
 
β
 
 (E2, 10
 
–9
 
 M). The
TGF-
 
α
 
 antibody treated with excess human TGF-
 
α
 
 (1 ng) for 30 min
at room temperature was also added to the medium with E2. The
medium containing the antibody and E2 was changed daily. After a
5-day exposure to the antibody specific to TGF-
 
α
 
, a 5-bromo-2'-
deoxyuridine (BrdU) solution of the cell proliferation kit (Amersham)
was added to the culture media (3 mg/ml) for 12 hr to assess DNA-
replicating cells. The cultured cells were fixed in Bouin’s solution for
30 min at room temperature, and immunocytochemical detection
was performed as described previously (Oomizu
 
 et al.,
 
 2000).
 
Quantification of the immunolabelled cells
 
Cells were observed under a light microscope at 
 
×
 
600 magni-
fication. The fields were scanned across the coverslip to avoid over-
lap. In each field, immunopositive and immunonegative cells were
counted, and more than 1000 cells were observed from each cov-
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erslip. The percentages of BrdU-labelled cells indicate those of cells
that had a densely labelled nucleus in relation to the total cells.
Each group consisted of three coverslips.
Ovariectomy and estrogen treatment
Two-month-old female mice were ovariectomized under ether
anesthesia. Seven days after the ovariectomy a single subcutane-
ous injection of E2 (Sigma Chemical Co.) was given at a dose of
250 ng in 0.05 ml of sesame oil. Ovariectomized female mice
treated with sesame oil only served as controls. Pituitaries were
obtained 48 hr after the E2 injection.
cDNA synthesis and PCR amplification
Total RNA (2 µg) in a final volume of 20 µl was subjected to
reverse transcription using Superscript II Reverse Transcriptase
(Gibco-BRL) with random primers according to the manufacturer’s
instructions. Each PCR was performed using primer pairs specific
for TGF-α, as described, and primer pairs specific for β-actin, as
based on a previous report (Matsuda and Mori, 1997). The size of
the resulting DNA fragment following PCR amplification was 502
base pairs (bp) for TGF-α and 469 bp for β-actin. These primers
generate PCR products of 502 bp for TGF-α and 469 bp for β-actin
respectively. These primers were synthesized by Gibco BRL Cus-
tom Primers, Life Technologies Asia Pacific (Yokohama, Japan).
PCR was performed using Takara Taq (Takara, Otsu, Japan) and
a thermal cycler (Gene Amp PCR System 9700, Applied Biosys-
tems, Branchburg, NJ). The conditions for PCR were as follows:
after activation of DNA polymerase by a 20-sec incubation at 95°C,
40 cycles (for TGF-α cDNA) and 25 cycles (for β-actin cDNA) of
reactions, including denaturation for 30 sec at 95°C and extension
for 1 min at 60°C, followed by an additional extension for 10 min at
60°C.
A 10-µl aliquot of each reaction was electrophoresed on 2%
agarose gel, stained with ethidium bromide, and photographed
under ultraviolet rays.
Statistics
Data are presented as the mean±S.E.M and were analyzed by
analysis of variance followed by Duncan’s multiple range tests.
RESULTS
Detection of TGF-α mRNA in the anterior mouse pituitary
by Northern blot analysis
Northern blot analysis using the mouse TGF-α cDNA
probe revealed that a single band of TGF-α mRNA (4.7 kb)
was expressed in the mouse anterior pituitary gland (Fig. 1).
In situ hybridization analysis of TGF-α mRNA-express-
ing cells
TGF-α mRNA-expressing cells were found to be evenly
distributed throughout the anterior pituitary gland, but not
the intermediate or posterior lobes (Fig. 2A). TGF-α mRNA-
expressing cells were round, oval, and medium-sized (Fig.
2B). In control experiments for in situ hybridization, no signal
was detected when DIG-labelled pBR328 probes were used
as controls (Fig. 2C). In adult male pituitaries, TGF-α
mRNA-expressing cells accounted for 65% (±2.1, n=3) of
the total pituitary cells, and for 55% (±1.7, n=3) in adult
female pituitaries.
Fig. 1. Northern blot analysis of pituitary TGF-α mRNA. Total RNA
(10 µg) obtained from adult female mice was electrophoresed on a
1% agarose gel and then transferred to a nylon membrane. The
membrane was hybridized with 32P-dCTP-labelled mouse TGF-α
cDNA probes. The relative positions of the 28S and 18S ribosomal
RNAs are shown.
Fig. 2. TGF-α mRNA expression in the male mouse pituitary was
analyzed by in situ hybridization. A: TGF-α mRNA-expressing cells
were evenly distributed throughout the anterior pituitary. TGF-α
mRNA-expressing cells were observed in a subpopulation of secre-
tory cells in the anterior lobe (a), but not in the intermediate (i) or
posterior lobes (p). Bar=50 µm B: TGF-α mRNA-expressing cells in
the anterior pituitary (arrow) were round, oval and medium sized.
Bar=10 µm C: In situ hybridization using pBR328 DIG-labelled
probes detected no signals in the anterior pituitary cells. Bar=10 µm
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Characterization of TGF-α mRNA-expressing cells
For the determination of the cell types of TGF-α mRNA-
expressing cells, serial sections were studied by non radio-
isotopic in situ hybridization using cDNA probes for TGF-α
mRNA (Fig. 3A and 3C), GH mRNA (Fig. 3B) and PRL
mRNA (Fig. 3D). Most of the GH mRNA-expressing cells
contained TGF-α mRNA (79–83%), whereas only a small
population of PRL mRNA-expressing cells contained TGF-α
mRNA (1–3%).
Effects of anti-TGF-α antibody treatment on DNA replica-
tion in pituitary cells
E2 treatment for 5 days significantly increased the
percentage of BrdU-labelled cells (p<0.01). Treatment of
pituitary cells with a combination of E2 and anti-TGF-α anti-
bodies did not increase the number of BrdU-labelled cells
(Fig. 4). The TGF-α antibody with excess TGF-α did not
affect E2-induced increase in the percentage of BrdU-
labelled cells.
RT-PCR analysis of TGF-α mRNA levels
To determine the effects of E2 on TGF-α gene expres-
sion, the relative TGF-α mRNA content was measured using
semiquantitative RT-PCR. The technical validation of this
assay is depicted in Fig. 5A,B. Various amounts of RT prod-
ucts (in volume, 0.5, 1, 1.5, 2 µl) for TGF-α and β-actin
cDNAs were amplified to ensure linearity for the PCR-ampli-
fication (Fig. 5A). The PCR products for TGF-α mRNA and
β-actin mRNA increased in accordance with the increase in
RT products (templates). TGF-α mRNA levels were deter-
Fig. 3. Determination of TGF-α mRNA-expressing cell types by in situ hybridization using serial sections of the anterior pituitary glands from
adult male (A and B), and female (C and D) mice. In situ hybridization was carried out using cDNA probes for TGF-α mRNA (A and C), GH
mRNA (B) and PRL mRNA (D). Paired photographs of A and B, and those of C and D are adjacent sections obtained from the serial sections
of mouse pituitary glands (5 µm thick), respectively. The cells (#1, #2, #3 and #4) expressed both TGF-α mRNA and GH mRNA. The cells (#5)
expressed both TGF-α mRNA and PRL mRNA, while the cells (#6 and #7) expressed PRL mRNA, but not TGF-α mRNA. Bar=20 µm
Fig. 4. Effect of E2 and anti-TGF-α antibody on the number of
BrdU-labelled pituitary cells. After a 3-day culture in serum-free
DME/F12 medium, an antibody specific for human TGF-α (1 µg
IgG1) was added to the medium (500 µl) for 5 days with estradiol-
17β (E2, 10–9 M). After the exposure to E2 and the antibody, BrdU
solution was added to the culture media for 12 hr to assess DNA
synthesizing cells. E2 treatment increased the number of BrdU-
labelled cells compared with the control (*p<0.01). Treatment with a
combination of anti-TGF-α antibody and E2 decreased the number
of BrdU-labelled cells compared with E2 treatment (#p<0.01).
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mined using 1 µl of RT product, and were normalized
according to the intensity of the co-amplified β-actin cDNA
value. PCR analysis under this condition revealed an
increase in TGF-α mRNA levels in response to E2 treatment
compared with the control treatment (Fig. 5C).
DISCUSSION
It is well known that estrogen stimulates the mam-
motroph proliferation (Lloyd et al., 1975; Takahashi and
Kawashima, 1987). We have recently shown that estrogen-
induced growth is inhibited by treatment with RG-13022, a
specific inhibitor for EGF receptors in adult mouse pituitaries.
TGF-α treatment stimulates DNA replication of pituitary cells
(Oomizu et al., 2000). Accordingly, these results suggest
that the estrogen-induced DNA replication of pituitary cells
is mediated by TGF-α through the EGF-receptor signaling
pathway. However, as far as we know, the cell types of
TGF-α-expressing cells have not previously been studied in
mouse pituitaries, and the mechanism of TGF-α leading to
DNA replication within the pituitary gland has remained
unclear. We have demonstrated in the present study that
TGF-α mRNA is expressed only in the anterior lobe, but not
the intermediate and posterior lobes. Treatment with an anti-
body specific for TGF-α appears to reduce estrogen-
induced DNA replication, clearly indicating that TGF-α acts
on mammotrophs as paracrine regulator for pituitary func-
tions through EGF receptors.
We found a 4.7-kb band for TGF-α mRNA in the ante-
rior pituitary by Northern blot analysis using mouse TGF-α
cDNA. TGF-α mRNA of similar size has previously been
detected in other mouse tissues (Tamada et al., 1991). In
the present study, TGF-α was detected primarily in soma-
totrophs and in some of the mammotrophs in the mouse
pituitaries. We did not study the other types of pituitary cells
for TGF-α mRNA expression. TGF-α mRNA-expressing
cells made up 55–65% of anterior pituitary cells in the
present study, and most of the somatotrophs expressed
Fig. 5. Analyses of TGF-α and β-actin mRNAs amplified by RT-PCR. Effect of E2 treatment on the amount of TGF-α mRNA was studied in
the pituitary cells of ovariectomized mice. E2
 
was subcutaneously injected to the ovariectomized mice at a dose of 250 ng/mouse. Pituitaries
were obtained after 48 hr of the injection. RNA samples were collected and subjected to RT-PCR. A: The analysis of the linearity of TGF-α and
β-actin cDNAs in relation to the amount of RT products. PCR amplification was carried out with various amounts of (0.5–2 µl) of the RT prod-
ucts (for TGF-α and β-actin) from controls and E2-treated mice. Each PCR product was electrophoresed on a 2% agarose gel, stained with
ethidium bromide, and photographed under UV irradiation. The number above the gel pictures depict the amount of RT products (µl). The band
intensities of TGF-α and β-actin cDNAs were increased with increasing amount of RT products. B: The analysis of quantiataive changes in the
bands depicted in A. The relative amounts of TGF-α mRNA were normalized according to the β-actin mRNA levels in each sample. C: The
summary of the change of TGF-α mRNA levels induced by E2 treatment. The TGF-α mRNA levels were normalized as performed in B, and the
relative values were expressed by regarding the control value as 1.0. Each column represents the mean (±S.E.M) of three independent exper-
iments. For the semiquantitative analysis of the relative amounts of TGF-α mRNA the band intensities of 1 µl of RT product were used.
*p<0.01, significantly different from the control.
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TGF-α mRNA. It is well known that somatotrophs account
for almost half of the total anterior pituitary cells (Sasaki and
Iwama, 1988). Therefore, most TGF-α mRNA-expressing
cells seem to be somatotrophs in mouse pituitaries. On the
other hand, Kobrin et al. (1987) has localized immunoreac-
tive TGF-α in mammotrophs and possibly in somatotrophs
in the bovine anterior pituitary. In human pituitary TGF-α is
localized in somatotrophs (Finley et al., 1994). Fan and
Childs (1995) have reported based on in situ hybridization
results that somatotrophs, gonadotrophs, and mammotro-
phs express TGF-α mRNA in the rat pituitaries. The discrep-
ancy in the cell types of TGF-α-mRNA expressing cells
among these reports may in part be due to the difference in
the animal species examined. In rat and mouse pituitaries,
somatotrophs and mammotrophs are closely located and
are distributed evenly throughout the anterior lobes of the
pituitary glands. Based on these findings, it is very likely that
the TGF-α produced in somatotrophs acts on adjacent
mammotrophs in a paracrine manner to stimulate DNA rep-
lication of mammotrophs.
Pituitary TGF-α expression is regulated under the influ-
ence of hormones, neurotransmitters, and other growth fac-
tors (Kobrin et al., 1987; Borgundvaag et al., 1992). Acute
estrogen treatment increases TGF-α mRNA levels in the
mouse anterior pituitary. Similarly, chronic estrogen treat-
ment stimulates TGF-α gene expression in rat pituitaries
(Borgundvaag et al., 1992). Furthermore, blockage of TGF-
α synthesis by treatment with antisense oligodeoxynucle-
otide for TGF-α mRNA decreases estrogen-induced DNA
replication in mammotrophs (Oomizu et al., 2000). Alto-
gether, these findings have led us to hypothesize that
estrogen-induced TGF-α expression is involved in the DNA
replication in pituitary cells.
Cell proliferation in the females has been found to fluc-
tuate during the estrous cycle, with the highest activity being
at estrus (Takahashi et al., 1984; Oishi et al., 1993). This
high proliferation of mammotrophs depends upon ovarian
estrogen, since ovariectomy decreases the high levels of
mitotic activity observed at estrus (Takahashi et al., 1984).
As TGF-α expression is stimulated by estrogen, the high
proliferation rate of mammotrophs at estrus may be pro-
duced by the enhanced TGF-α release induced by high
estrogen titers during a proestrous day. Accordingly, it is
necessary to study a change in TGF-α gene expression dur-
ing the estrous cycle in female mice.
We have recently reported detecting EGF-R mRNA in
the mouse pituitary (Honda et al., 2000). Fan and Childs
(1995) have also found that all subsets of rat pituitary cells
express EGF-Rs. EGF-R expression changes with various
conditions such as stress and the estrous cycle (Fan and
Childs, 1995; Armstrong and Childs, 1997; Armstrong and
Childs, 1997). Moreover, estrogen stimulates EGF-R levels
in the rat uterus (Mukku and Stancel,1985). Similarly, estrogen
treatment with E2 increases both EGF-R mRNA (Oomizu et
al., 2000) and TGF-α mRNA levels in the mouse pituitary.
Thus, estrogen appears to stimulate pituitary growth at the
level of both TGF-α and EGF receptor production.
Roh et al. (2001) has shown that EGF-R signaling is
required for the differentiation of pituitary cells only in early
pituitary organogenesis. The overexpression of human TGF-
α induced in transgenic mice accelerates the development
of pituitary mammotrophic adenoma (McAndrew et al.,
1995). In pituitary tumor cells, TGF-α affects cell prolifera-
tion in either a stimulatory or inhibitory manner (Ramsdell,
1991; Finley and Ramsdell, 1994). Thus, TGF-α is involved
in the growth of normal and tumor pituitary cells. However,
it remains to be determined whether factors such as age
and sex affect the TGF-α-induced proliferation of pituitary
cells in mice.
In conclusion, we have shown in the present study that
estrogen acts on somatotrophs to stimulate TGF-α synthe-
sis, and that this TGF-α acts on pituitary cells to stimulate
DNA replication. It is known that TGF-α stimulates the pro-
liferation of mammotrophs (Oomizu et al., 2000). Therefore,
these findings suggest that estrogen induced growth of
mammotrophs is governed by at least the presence of TGF-
α-producing somatotrophs.
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